Latest Updates
-
Gold Rate In India Crash By Rs 12,000 From Record: Will 24K, 22K, 18K Gold Prices Rise Or Fall In Christmas Week? Gold & Silver Prediction Here -
20th or 21st December? When Is the Winter Solstice In 2025 And How Is It Different From Meteorological Winter -
‘Clean Air Is a Right, Not a Luxury’: ZONAIR3D Unveils India Expansion Plans -
World Meditation Day 2025: Meditation Beyond The Mat, Simple Moments That Bring Inner Peace -
Sreenivasan Passes Away: Malayalam Cinema Mourns The Legendary Actor-Writer's Demise -
Malayalam Film Industry Loses A Defining Voice: Actor, Screenwriter And Director Sreenivasan Passes Away At 69 -
Happy Birthday Dheeraj Dhoopar: How A TV Set Friendship Turned Into Love With Wife Vinny Arora -
Top Skin and Hair Concerns in India in 2025: What the Data Reveals -
International Human Solidarity Day 2025: History, Significance, and Why It Matters -
Purported Video of Muslim Mob Lynching & Hanging Hindu Youth In Bangladesh Shocks Internet
Gene Therapy For Blindness Improves Vision
Researchers from University of Florida and University of Pennsylvania have successfully able to restore vision among patients with a rare form of congenital blindness using gene therapy, thus showing that the treatment is fully safe.
In Leber Congenital Amaurosis type 2 disease, photoreceptor cells cannot respond to light because a gene called RPE65 does not properly produce a protein necessary for healthy vision.
Researchers used an adeno-associated virus — an apparently harmless virus that already exists in most people to deliver RPE65 to a small area of the retina. The results showed that not only were there no ill effects other than routine post surgical soreness, the vision in the subjects" treated eyes was slightly improved in dim lighting conditions.
"The patients report seeing brighter areas and perhaps some images, but basically the message is that this is treatment is fully safe," said William W. Hauswirth, Ph.D., a professor of ophthalmology and member of UF's Powell Gene Therapy Centre and the UF Genetics Institute.
"One thing we did not do is suppress the patients' immune systems, which was done in two other LCA clinical trials that were under way," said Hauswirth, who began studying the adeno-associated virus as a vehicle to deliver genes into living animals more than 30 years ago.
"Theoretically, the idea was that it might be necessary to suppress the immune system because we are using a vector that might activate the body's defenses and cause a harmful response.
"However, immune suppression itself carries a risk of infections and other problems. Clearly we have shown there is no need to do that in this case," he added.
"The
study
has
partially
restored
vision
in
three
young
adults,
and
it
demonstrates
that
gene
therapy
can
be
effective
in
treating
human
vision
disease,"
said
Paul
A.
Sieving,
M.D.,
Ph.D.,
director,
National
Eye
Institute
of
the
National
Institutes
of
Health.
The
paper
is
published
online
today
in
Human
Gene
Therapy.
Disclaimer: The information provided in this article is for general informational and educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or a qualified healthcare provider with any questions you may have regarding a medical condition.



Click it and Unblock the Notifications











